Journal article
Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials
Abstract
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of coronavirus disease 2019 (COVID-19). Conventional meta-analyses cannot fully address the heterogeneity of different designs and outcomes of randomized controlled trials (RCTs) assessing the efficacy of HCQ in outpatients with mild COVID-19. We conducted a pooled analysis of individual participant data from RCTs that evaluated the effect of HCQ on …
Authors
Mitjà O; Reis G; Boulware DR; Spivak AM; Sarwar A; Johnston C; Webb B; Hill MD; Smith D; Kremsner P
Journal
Clinical and Translational Science, Vol. 16, No. 3, pp. 524–535
Publisher
Wiley
Publication Date
March 2023
DOI
10.1111/cts.13468
ISSN
1752-8054